REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 17th, 2017 • Capstone Therapeutics Corp. • Pharmaceutical preparations • Delaware
Registration Rights Agreement (this “Agreement”), dated as of July 14, 2017, by and between Capstone Therapeutics Corp., a Delaware corporation located at 1275 West Washington Street, Suite 104, Tempe, Arizona 85281 (the “Company”), and BP Peptides, LLC, a Delaware limited liability company located at 122 East 42nd Street, Suite 4305, New York, New York 10168 (the “Investor”).
ContractPromissory Note • July 17th, 2017 • Capstone Therapeutics Corp. • Pharmaceutical preparations
THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR QUALIFIED UNDER APPLICABLE STATE SECURITIES LAWS. THIS SECURITY MAY NOT BE SOLD OR OTHERWISE TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION AND QUALIFICATION WITHOUT, EXCEPT AS OTHERWISE AGREED TO BY BORROWER, AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO BORROWER THAT SUCH REGISTRATION AND QUALIFICATION ARE NOT REQUIRED.
SECURITIES PURCHASE, LOAN AND SECURITY AGREEMENTSecurities Purchase, Loan and Security Agreement • July 17th, 2017 • Capstone Therapeutics Corp. • Pharmaceutical preparations • Delaware
SECURITIES PURCHASE, LOAN AND SECURITY AGREEMENT (this “Agreement”), dated as of July 14, 2017, by and between Capstone Therapeutics Corp., a Delaware corporation located at 1275 West Washington Street, Suite 104, Tempe, Arizona 85281 (the “Company”), and BP Peptides, LLC, a Delaware limited liability company located at 122 East 42nd Street, Suite 4305, New York, New York 10168 (the “Buyer”).
